MAPK3 and permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome: To estimate the cell signalling phosphoprotein, p-ERK1/2, as a novel serum biomarker to detect PaCa patients, we calculated the ROC curves, which correlate the true- and false-positive rates (sensitivity and 1 specificity) between PaCa patients and HVs.